News

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic cooperation agreement

Abu Dhabi has cemented its position as a global hub for biotechnology, medical technology and digital health with the opening of a groundbreaking life sciences complex

NLS Pharmaceutics Ltd. a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS)

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies

PRISM BioLab, Co. Ltd. a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo® plus Yervoy® as a first-line treatment

Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss

Isotopia Molecular Imaging is proud to announce the official launch of Isoprotrace®, its advanced Gallium-68 Gozetotide